SCHEMBL25545547

SCHEMBL25545547

COCCOc1ccc(-c2nc(Cl)sc2CCC(C)C)cc1F

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 6/20 0.36
FBP1 P09467 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
TLR7 Q9NYK1 1/20 0.33
S1PR4 O95977 1/20 0.33
DCK P27707 2/20 0.33
NR1H4 Q96RI1 1/20 0.32
HTR2C P28335 2/20 0.32
HTR2B P41595 1/20 0.32
ALDH1A1 P00352 2/20 0.31
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
HPGD P15428 1/20 0.31
HTT P42858 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PTGES O14684 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25546022 0.92 TRPV1 (0.35) FBP1TRPV1DCKHTR2CHTR2B
SCHEMBL25545564 0.90 S1PR4 (0.35) AAK1TLR7S1PR4HTR2CHTR2B
SCHEMBL25545528 0.89 FBP1 (0.43) AAK1FBP1S1PR4DCKHTR2C
SCHEMBL25545544 0.89 S1PR4 (0.37) FBP1TRPV1S1PR4HTR2CHTR2B
SCHEMBL25545560 0.88 HTT (0.40) FBP1TLR7S1PR4DCKHTR2C
SCHEMBL25545930 0.88 ALDH1A1 (0.41) AAK1ALDH1A1PTGS1PTGS2HTT
SCHEMBL25545990 0.88 FBP1 (0.42) AAK1FBP1S1PR4DCKHTR2C
SCHEMBL25546020 0.87 TRPV1 (0.43) FBP1TRPV1DCKHTR2CHTR2B
SCHEMBL25545551 0.84 FBP1 (0.43) AAK1FBP1TLR7S1PR4ALDH1A1
SCHEMBL25545533 0.83 AAK1 (0.36) AAK1TRPV1TLR7S1PR4DCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 AAK1 1064/4885FBP1 735/4885TRPV1 4604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.